Dr. Ajay Goel Joins Cizzle Bio as Scientific Advisor
We are thrilled to announce that Dr. Ajay Goel, a globally recognized cancer researcher and molecular diagnostics expert, has joined Cizzle Bio, Inc. as a Scientific Advisor. With over 25 years of experience in cancer research and biomarker development, Dr. Goel’s unparalleled expertise will support our mission to revolutionize early cancer detection.
A Leader in Cancer Research
Dr. Goel serves as the Founding Chair of the Department of Molecular Diagnostics at the Beckman Research Institute and holds numerous leadership roles at the City of Hope Comprehensive Cancer Center, including Associate Director of Basic Sciences and Director of Biotech Innovations. His groundbreaking research has led to:
450+ peer-reviewed articles published in leading journals.
An H-index of 110, reflecting his significant influence in cancer diagnostics and therapeutics.
75+ international patents, pioneering biomarkers and therapeutic targets for gastrointestinal cancers.
Advancing Early Cancer Detection
Dr. Goel’s work focuses on leveraging liquid biopsy-based biomarkers to advance early cancer detection and precision medicine. His expertise includes:
Developing cell-free nucleic acid and exosomal biomarkers for gastrointestinal cancers.
Using genomic and transcriptomic approaches to identify novel therapeutic targets.
Exploring the role of the gut microbiome in cancer prevention and health disparities.
Contributions to the Scientific Community
Dr. Goel’s contributions extend far beyond research. He serves on the editorial boards of over 25 international journals, including Clinical Cancer Research and Gastroenterology, and is a key member of several prominent organizations, including the:
What This Means for Cizzle Bio
Dr. Goel’s appointment as a Scientific Advisor marks a significant milestone for Cizzle Bio as we continue to push boundaries in early cancer detection. His insights will play a vital role in refining our diagnostic technologies, including the development of innovative biomarkers for diseases like gastric and lung cancer.
A Shared Vision for the Future
Dr. Goel’s dedication to advancing precision medicine and improving outcomes for cancer patients aligns perfectly with Cizzle Bio’s mission: “Detect Early, Save Lives.” Together, we are poised to redefine the future of cancer diagnostics.
We are honored to welcome Dr. Ajay Goel to the Cizzle Bio team and look forward to the groundbreaking advancements his expertise will bring.
